Nacolomab tafenatox
From Self-sufficiency
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Template:Infobox drug/mab source |
| Target | colorectal tumor antigen C242 |
| Identifiers | |
| CAS Number | 150631-27-9 |
| ATC code | none |
Nacolomab tafenatox is a mouse monoclonal antibody[1] designed for the treatment of colorectal cancer.[citation needed] The antibody itself, nacolomab, is fused with enterotoxin A from Staphylococcus aureus (which is reflected by 'tafenatox' in the drug's name).[1]
File:Fab-superantigen-fusion protein.svg
Schematic image of nacolomab tafenatox.
VH, VL: variable (antigen binding) domains of antibody fragment
CH1, CL: constant domains of antibody fragment
SAg: enterotoxin A (acting as a superantigen)
VH, VL: variable (antigen binding) domains of antibody fragment
CH1, CL: constant domains of antibody fragment
SAg: enterotoxin A (acting as a superantigen)
See also
- Naptumomab estafenatox, a drug with a similar chemical structure and mechanism
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles which use infobox templates with no data rows
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from October 2009
- Articles with invalid date parameter in template
- Pages with broken file links
- 2Fix
- Cancer treatments
- Monoclonal antibody stubs
